Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
07/2007
07/18/2007CN100999476A Triamido monomer and its synthesizing process and use
07/12/2007WO2007077140A1 Hydroxy-norephedrine derivatives and processes for their preparation
07/11/2007EP1806351A2 Amino acid-derived cyclic phosphonamides and methods of synthesizing the same
07/11/2007EP1806335A1 Method for producing phenylethanolamine compound and intermediate thereof
07/11/2007EP1806332A1 Benzene compound having 2 or more substituents
07/11/2007EP1805131A2 Ionic liquids comprising nitrogen containing cations
07/11/2007CN1997620A Ionic liquids comprising nitrogen containing cations
07/11/2007CN1326153C Nonaqueous electrolyte, electrical double layer capacitors, and nonaqueous electrolyte secondary cells
07/11/2007CN1325466C Calcilytic compounds
07/11/2007CN1325465C High purity (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof, preparation and the me
07/10/2007US7241810 For therapy of inflammatory, allergic and respiratory diseases
07/10/2007US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
07/10/2007US7241774 Amines such as 6,7-bis-hydroxy-1-biphenyl-4-ylmethyl-1,2,3,4-tetrahydro-isoquinoline, used as preferential anticarcinogenic agents
07/10/2007US7241721 carboxamide derivatives as active ingredients which have microbiocidal activity, in particular fungicidal activity
07/10/2007US7241715 Dianionic chelating ligands with a bridged-bis-bi-aryl structure; For catalytic polymerization of ethylene/olefin copolymers
07/10/2007US7241513 Fluorene compound and organic luminescent device using the same
07/05/2007WO2007074047A1 Method for producing o-alkylated cyclic aminoalcohols
07/05/2007WO2007074046A2 Method for producing o-alkylated aminoalcohols
07/05/2007US20070155820 Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
07/05/2007US20070155819 Calcilytic compounds
07/05/2007US20070155813 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression
07/04/2007EP1803705A1 Aromatic diamine and process for producing the same
07/04/2007EP1802630A2 Trityl derivatives for enhancing mass spectrometry
07/03/2007CA2244662C Antifungal agents
07/03/2007CA2219655C Process for the catalytic hydrogenation of aromatic nitro compounds
07/03/2007CA2156162C Cancer treatment
06/2007
06/28/2007WO2007039125A3 An optically active thyroid receptor agonist and optically active key intermediates in its production
06/28/2007US20070149813 Process for preparation of phenethylamine derivatives
06/28/2007US20070149614 Guanidine and amidine acid derivatives and analogs and methods of using the same
06/28/2007US20070149608 3-(4-Benzyloxyphenyl) propanoic acid derivatives
06/26/2007US7235693 Process for chlorinating tertiary alcohols
06/26/2007US7235312 Aromatic compounds and organic electroluminescent devices made by using the same
06/26/2007US7235194 include a bridge of pi-conjugated bonds connecting electron donating or accepting groups; upon absorption, one or more Lewis acidic species, Lewis basic species, radical species or ionic species are formed
06/21/2007WO2007069712A1 Amine compound and use thereof for medical purposes
06/21/2007WO2007069277A2 A process for the preparation of venlafaxine hydrochloride
06/21/2007WO2007068929A1 Cyclic amine derivatives and their uses
06/21/2007WO2007068324A1 Polymorph of atomoxetine hydrochloride in crystalline form
06/21/2007WO2007047972A3 Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl) ethyl]cyclohexanol hydrochloride
06/21/2007US20070142681 Process for chlorinating tertiary alcohols
06/21/2007US20070142670 e.g., N-(1-[3,5-bis(trifluoromethyl)phenyl]ethyl)-N-methyl-N-(1-phenylethyl)amine; intermediates for medicines and agricultural chemicals
06/21/2007US20070142445 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives
06/21/2007US20070142381 Calcium receptor modulating agents
06/21/2007US20070142379 Cyclohexyl derivatives as selective estrogen receptor modulators
06/21/2007CA2633374A1 Amine compound and use thereof for medical purposes
06/21/2007CA2633229A1 Polymorph of atomoxetine hydrochloride in crystalline form
06/20/2007EP1798217A1 Anticancer agents based on regulation of protein prenylation
06/20/2007EP1798216A1 Intermediate of 6-substituted-1-methyl-1-h-benzimidazole derivative and method for producing same
06/20/2007EP1798215A1 Polymorph of atomoxetine hydrochloride in crystalline form
06/20/2007EP1441827A4 Branched reaction products
06/20/2007CN1984873A Method for the continuous production of an amine
06/20/2007CN1982286A Calixarene-ethanolamine derivative, its production and use as metal-ion fluorescent identification agent
06/20/2007CN1321964C Lightfast additive having uv-absorbing moiety and ink composition including the same
06/19/2007US7232847 4-aminocyclohexanones are reduced with methoxytriphosphonium chloride and sodium hydride, then with HCl, producing aldehydes; etherifying the alcohol with trimethylchlorosilane; active at opioid receptors such as the mu receptor; analgesics
06/14/2007WO2007067501A1 Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
06/14/2007US20070135505 Aralkyl ester soft drugs
06/14/2007US20070135490 Phenetanolamine derivatives
06/14/2007CA2629609A1 Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
06/13/2007EP1795524A1 Cyclic amine derivative or salt thereof
06/13/2007EP1793667A1 Alkoxylated alkylamines / alkyl ether amines with peaked distribution
06/13/2007CN1980894A Compounds and compositions as PPAR modulators.
06/12/2007US7230134 By reacting aldehydes or ketones with ammonia or primary/secondary amines in presence of hydrogen-donor and homogeneous transition metal/complex catalysts
06/12/2007US7230030 Ether, alcohol, ester, carbamate or carbonate,sulfamate or silanol substituted-3,3-diphenylpropylamine derivatives; prodrugs of antimuscarinic agents with superior pharmacokinetic properties
06/07/2007WO2007064697A1 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
06/07/2007US20070129433 Diphenylamine derivatives
06/06/2007EP1792893A1 Aromatic amine derivative and organic electroluminescent device using same
06/06/2007EP1791807A1 Therapeutic diphenyl ether ligands
06/06/2007CN1976894A Polymorphs of atomoxetine hydrochloride
06/06/2007CN1974541A Prepn process of (Z)-3'-amino-3,4,4', 5-tetramethoxyl stilbene
06/06/2007CN1319936C Tertiary alkanolamine containing tensioactive alkyl group
06/05/2007US7226950 Sodium channel modulators
06/05/2007US7226487 Oxidative dyeing keratin fibers
05/2007
05/31/2007WO2007062119A1 Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
05/31/2007US20070123707 Nitrogen-containing monodentate phosphines and their use in catalysis
05/31/2007CA2629800A1 Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
05/30/2007EP1790337A2 Methods and compounds for treating depression and other disorders
05/30/2007EP1013651B1 O-(perfluoroalkyl)dibenzofuranium salt derivatives, intermediates for the preparation of the same, process for the preparation of the intermediates, perfluoroalkylating agents, and process for perfluoroalkylation
05/30/2007CN1318479C Novel diaminobenzene derivative, polyimide precursor and polyimide obtained therefrom, and aligning agent for liquid crystal
05/29/2007USRE39667 3,3-Diphenylpropylamines, their use and preparation
05/29/2007US7223879 Reactibng transition metal with boron compound and sulfonate compound
05/29/2007US7223798 treating inflammatory or autoimmune disorders and pulmonary or respiratory tract inflammation
05/24/2007US20070117870 Enantiomers of N-Desmethyl venlafaxine
05/23/2007CN1317257C Nitrogen-containing ortho ester-based surfactant, its preparation and use
05/22/2007US7220883 Process for the preparation of primary amines
05/22/2007US7220783 Para-terphenyl compounds
05/18/2007WO2007055180A1 Method for producing optically active trans-2-aminocyclohexanol and derivative thereof
05/17/2007US20070112232 Reacting halogen and hydroxy substituted aromatic compounds with an alkali metal or in a nitrogen base and an alcohol; hydroxyl group prevents dehalogenation; selectively retaining a halogen group on an aromatic ring
05/16/2007EP1785412A1 Tramadol recovery process
05/16/2007EP1784382A1 P-diaminobenzole-derivatives and dyes containing said compounds
05/16/2007EP1784381A1 Novel substituted aryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors
05/16/2007CN1315781C Preparation of 4-amino-1-naphthol ethers
05/15/2007US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
05/10/2007WO2007053755A1 Process for preparing substituted anisidines
05/10/2007WO2007051576A1 Process for preparing substituted dimethyl(3-arylbutyl)amine compounds by means of homogeneous catalysis
05/10/2007WO2007025709A3 Organic compounds
05/10/2007WO2005111050A3 Enantioselective phosphoramidite compounds and catalysts
05/10/2007US20070105958 Compounds for the treatment of metabolic disorders
05/10/2007US20070105949 Intermediates for the preparation of lipoxin A4 analogs
05/10/2007CA2625419A1 Process for preparing substituted anisidines
05/09/2007EP1783158A1 Fluorine-containing polymerizable monomer and polymer compound using same
05/09/2007EP1783110A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 140